Jacobs Levy Equity Management, Inc Amicus Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $13.2 Million - $20.9 Million	-1,675,373 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $1.32 Million - $1.67 Million	-134,419 Reduced 7.43%	1,675,373 $19.4 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $736,467 - $997,685	84,264 Added 4.88%	1,809,792 $17.3 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $12.8 Million - $15.7 Million	1,467,313 Added 568.25%	1,725,528 $16.6 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $2.38 Million - $6.16 Million	258,215 New	258,215 $2.55 Million
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $1.2 Million - $2.02 Million	-181,176 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $1.21 Million - $1.74 Million	162,076 Added 848.57%	181,176 $1.77 Million
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $15,238 - $25,175	1,900 Added 11.05%	19,100 $153,000
Q2 2019 Aug 13, 2019	BUY	$10.96 - $14.4 $188,512 - $247,680	17,200 New	17,200 $215,000
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $626,187 - $1 Million	-74,724 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $250,838 - $357,660	21,624 Added 40.72%	74,724 $903,000
Q2 2018 Aug 14, 2018	BUY	$13.13 - $17.09 $697,203 - $907,479	53,100 New	53,100 $829,000

312

311M

467K

515K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.58B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.